Immunomodulatory therapy in advanced multiple sclerosis - a podcast by BMJ Group

Could currently available immunomodulatory therapies modify disability trajectories in patients with moderately advanced and advanced multiple sclerosis (MS)?
Tomas Kalincik, Department of Medicine, University of Melbourne, Australia, discusses the findings from the MSbase cohort study with Elizabeth Highton.

Read the full article here: http://jnnp.bmj.com/content/88/3/196.

Further episodes of JNNP podcast

Further podcasts by BMJ Group

Website of BMJ Group